BI's Pradaxa set to replace warfarin in Scotland?
This article was originally published in Scrip
Executive Summary
Scotland's health technology assessment body, the Scottish Medicines Consortium, has okayed Boehringer Ingelheim's blood thinning drug Pradaxa (dabigatran etexilate) for preventing stroke and systemic embolism in adults with atrial fibrillation for use on the Scottish NHS.